Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation

S. A. Giralt, K. F. Mangan, R. T. Maziarz, J. S. Bubalo, R. Beveridge, D. D. Hurd, F. L. Mendoza, E. B. Rubenstein, T. J. DeGroot, M. W. Schuster

Research output: Contribution to journalArticle

31 Scopus citations

Fingerprint Dive into the research topics of 'Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences